Pegacril DX2 glue is a very fluid glue indicated for joining acrylic materials (PMMA) for extrusion and casting.
For gluing and bonding extrusion and casting methyl acrylic (PMMA) materials.
High-tech jobs in the industrial sector.
The parts to be treated must be stress-free, thus avoiding micro-cracks due to the action of the solvent.
High resistance when the glue has evaporated and the polymer is attached to the parts.
You can also carry out previous tests for gluing with other plastic materials.
Gluing with Pegacril DX2 glue is carried out indistinctly in extrusion and cast acrylic. The union is carried out by capillarity and evaporation of the solvent, leaving the polymer adhered to the pieces.
The edges to be glued must be perfectly flat to avoid the formation of bubbles.
Pegacril DX2 is applied with a small bottle or syringe fitted with a cannula or needle, on the edges of the pieces to be joined, exerting a little pressure on them. Handling is recommended in a dry place at a temperature of 20-24ºC. The gluing time is a few minutes and after this, Pegacril DX2 offers a colorless finish. It does not fill in the gaps completely. Pegacril DX2 should not be used if there is moisture condensation, as it can whiten the bond.
The transport and movement of the piece after gluing must take place after three hours. The pieces must be dried in the open air and without wrapping so that the solvent evaporates. Complete evaporation of residual solvent will take place after 48 hours in the open air.
To clean greases and static charges, it is recommended to use Netacril PT.
Minimum training in occupational risk prevention is recommended for the personnel who will handle this product, in order to facilitate the understanding and interpretation of this safety data sheet, as well as the labeling of the product.
Directive 67/548 / EC and Directive 1999/45 / EC:
Contains dichloromethane, nitromethane. UN 2810
The product classification has been carried out in accordance with RD 363/1995 (Directive 67/548 / CE) and RD255 / 2003 (Directive 1999/45 / CE), adapting their provisions to Regulation (CE) nº1907 / 2006 (REACH Regulation) according to RD 1802/2008. Carc. Cat 3: R40 - Possible carcinogenic effects, R22: Harmful if swallowed
Regulation No. 1272/2008 (CLP):
H302 - Harmful if swallowed. H351 - Suspected of causing cancer. H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness.